Screener
Bio-Rad Laboratories BIO Clinical Diagnostics — Goodwill, Period Increase (Decrease)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GoodwillPeriodIncreaseDecrease.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
| Balances as of December 31, 2025 | Life Science | Clinical Diagnostics | Total |
|---|---|---|---|
| Accumulated impairment losses | (41.8) | (293.4) | (335.2) |
| Goodwill, net | 451.4 | 128.4 | 579.8 |
| Foreign currency adjustments | (2.7) | — | (2.7) |
| Period change, net | (2.7) | — | (2.7) |
| Balances as of March 31, 2026 | |||
| Goodwill | 490.5 | 421.8 | 912.3 |
| Accumulated impairment losses | (41.8) | (293.4) | (335.2) |
| Goodwill, net | $448.7 | $128.4 | $577.1 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bio-Rad Laboratories's clinical diagnostics — goodwill, period increase (decrease)?
- Bio-Rad Laboratories (BIO) reported clinical diagnostics — goodwill, period increase (decrease) of $0 in Q1 2026.
- How has Bio-Rad Laboratories's clinical diagnostics — goodwill, period increase (decrease) changed year-over-year?
- Bio-Rad Laboratories's clinical diagnostics — goodwill, period increase (decrease) decreased by 100.0% year-over-year, from $4.1M to $0.
- What does clinical diagnostics — goodwill, period increase (decrease) mean?
- The net change in the goodwill balance for the Clinical Diagnostics segment during the reporting period, including new acquisitions, divestitures, and currency translation adjustments. It tracks the movement of intangible asset value over time.
Ask your AI about Bio-Rad Laboratories's clinical diagnostics — goodwill, period increase (decrease).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude